Maspin expression in normal lung and non-small-cell lung cancers: cellular property-associated expression under the control of promoter DNA methylation

被引:47
作者
Yatabe, Y [1 ]
Mitsudomi, T
Takahashi, T
机构
[1] Aichi Canc Ctr Hosp, Dept Pathol & Mol Diagnost, Chikusa Ku, Nagoya, Aichi 4648681, Japan
[2] Aichi Canc Ctr Hosp, Dept Thorac Surg, Nagoya, Aichi 464, Japan
[3] Aichi Canc Ctr, Res Inst, Div Mol Oncol, Nagoya, Aichi 464, Japan
关键词
maspin; non-small-cell lung cancers; intratumor heterogeneity; promoter DNA methylation; cellular properties;
D O I
10.1038/sj.onc.1207557
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Maspin has been demonstrated to be a suppressor of invasion and cell motility in vitro, whereas in vivo analyses have reported that increased expression of maspin is associated with malignant behavior. The present study examined maspin expression in normal lung and non-small-cell lung cancers. Only proximal airway cells in the normal lung expressed maspin, and the expression was associated with decreased methylation. This association was also observed in non-small-cell lung cancers, but the expression was quite different among histologic subtypes; 20 of 21 squamous cell carcinomas showed intense, uniform expression, whereas the expression status varied among adenocarcinomas. Of the 119 adenocarcinomas, 60 were negative, 23 positive and 36 showed a heterogeneous expression pattern. The expression was inversely correlated with markers of peripheral airway cells. Taken together, the results suggest that maspin may be expressed in association with the proximal airway cell type. It is of note that the heterogeneous expression pattern of maspin is quite distinctive, showing geographic positivity in the individual tumors. Separate analysis of methylation status in positive and negative portions of individual tumors provided an instance of intratumor diversity associated with promoter DNA methylation.
引用
收藏
页码:4041 / 4049
页数:9
相关论文
共 45 条
[1]  
Achiwa H, 1999, CLIN CANCER RES, V5, P1001
[2]   Maspin inhibits cell migration in the absence of protease inhibitory activity [J].
Bass, R ;
Fernández, AMM ;
Ellis, V .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (49) :46845-46848
[3]   Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses [J].
Bhattacharjee, A ;
Richards, WG ;
Staunton, J ;
Li, C ;
Monti, S ;
Vasa, P ;
Ladd, C ;
Beheshti, J ;
Bueno, R ;
Gillette, M ;
Loda, M ;
Weber, G ;
Mark, EJ ;
Lander, ES ;
Wong, W ;
Johnson, BE ;
Golub, TR ;
Sugarbaker, DJ ;
Meyerson, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (24) :13790-13795
[4]   Prognostic value of maspin mRNA expression in ERα-positive postmenopausal breast carcinomas [J].
Bièche, I ;
Girault, I ;
Sabourin, JC ;
Tozlu, S ;
Driouch, K ;
Vidaud, M ;
Lidereau, R .
BRITISH JOURNAL OF CANCER, 2003, 88 (06) :863-870
[5]   E-cadherin mediates aggregation-dependent survival of prostate and mammary epithelial cells through the retinoblastoma cell cycle control pathway [J].
Day, ML ;
Zhao, X ;
Vallorosi, CJ ;
Putzi, M ;
Powell, CT ;
Lin, C ;
Day, KC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (14) :9656-9664
[6]  
Domann FE, 2000, INT J CANCER, V85, P805, DOI 10.1002/(SICI)1097-0215(20000315)85:6<805::AID-IJC12>3.0.CO
[7]  
2-5
[8]   Role for DNA methylation in the control of cell type-specific maspin expression [J].
Futscher, BW ;
Oshiro, MM ;
Wozniak, RJ ;
Holtan, N ;
Hanigan, CL ;
Duan, H ;
Domann, FE .
NATURE GENETICS, 2002, 31 (02) :175-179
[9]   Diversity of gene expression in adenocarcinoma of the lung [J].
Garber, ME ;
Troyanskaya, OG ;
Schluens, K ;
Petersen, S ;
Thaesler, Z ;
Pacyna-Gengelbach, M ;
van de Rijn, M ;
Rosen, GD ;
Perou, CM ;
Whyte, RI ;
Altman, RB ;
Brown, PO ;
Botstein, D ;
Petersen, I .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (24) :13784-13789
[10]   Mucinous and nonmucinous bronchioloalveolar adenocarcinomas have distinct staining patterns with thyroid transcription factor and cytokeratin 20 antibodies [J].
Goldstein, NS ;
Thomas, M .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2001, 116 (03) :319-325